Adult Medicine PRN Focus Session — Hitting the Sweet Spot: Managing the Risks and Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in an Inpatient Population

This educational session will address the inpatient use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and GLP1 receptor agonists (GLP1-RA) for the general medicine practitioner. Specific topics will include 1) An assessment of SGLT2i use for hospitalized patients with non-diabetes indications; 2) Balancing the risk versus benefits of inpatient use of SGLT2i, including identifying adverse drug events (ADEs), re-initiation in patients who have risk factors for or history of ADEs, and mitigating cost; and 3) Considerations for hospitalized patients on GLP1-RA, including inpatient administration and re-initiation at discharge. This session aims to update adult medicine practitioners on how to manage common clinical scenarios where newer antihyperglycemic medications are used in hospitalized patients.

Moderator: Nicole L. Metzger, Pharm.D., FCCP, BCPS Clinical Professor, Department of Pharmacy Practice Mercer University College of Pharmacy Atlanta, GA Practice site at Emory University Hospital Atlanta, GA   View Biography

An Assessment of SGLT2i Use for Hospitalized Patients With Non-diabetes Indication 8:30 a.m. to 9:00 a.m. Speaker: Jessica A. Starr, Pharm.D., BCPS Clinical Professor of Pharmacy Practice Auburn University Harrison College of Pharmacy   View Biography

Balancing the Risk Versus Benefits of Inpatient Use of SGLT2i 9:00 a.m. to 9:30 a.m. Speaker: Calvin J. Meaney, Pharm.D., FCCP, BCPS Clinical Associate Professor University at Buffalo School of Pharmacy and Pharmaceutical Sciences Buffalo, New York   View Biography

Considerations for Hospitalized Patients on GLP1-RA 9:30 a.m. to 10:00 a.m. Speaker: Emily R. McElhaney, Pharm.D., BCCP Cardiology Clinical Pharmacy Specialist Cleveland Clinic Cleveland, Ohio   View Biography